• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上尿路尿路上皮癌中的林奇综合征:意义、筛查及监测

Lynch syndrome in upper tract urothelial carcinoma: significance, screening, and surveillance.

作者信息

Pradere Benjamin, Lotan Yair, Roupret Morgan

机构信息

aDepartment of Urology, CHRU Tours, Faculté de Médecine François Rabelais, Tours, Loire Valley, France bDepartment of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, USA cDepartment of Urology, Pitié-Salpétrière, Assistance-Publique Hôpitaux de Paris, Faculté de Médecine Pierre et Marie Curie, University Paris 6, Paris, France.

出版信息

Curr Opin Urol. 2017 Jan;27(1):48-55. doi: 10.1097/MOU.0000000000000340.

DOI:10.1097/MOU.0000000000000340
PMID:27533503
Abstract

PURPOSE OF REVIEW

Lynch syndrome is a genetic syndrome that integrates a large spectrum of cancers caused by germline mutations in mismatch repair genes. Its incidence is underestimated due to a lack of systematic screening in the population. Because upper tract urothelial carcinoma is the third-most common cancer associated with the syndrome, urologists should be aware of the diagnostic pathway.

RECENT FINDINGS

Lynch syndrome can be positively diagnosed after the three following distinct steps: meeting the clinical criteria, tissue and genetic testing, and familial genetic counseling. It must be suspected for patients with upper tract urothelial carcinoma before the age of 60 years and in cases of evocative personal/familial medical histories. When a diagnosis is suspected, immunohistochemistry and Polymerase Chain Reaction are the next steps to confirm the diagnosis. After confirmation, the key to management is a good surveillance to prevent disease recurrence using urinary analysis and imaging as well as screening of first-degree relatives.

SUMMARY

Despite the lack of high-level studies of upper tract urothelial carcinoma in Lynch syndrome, its prevalence is not negligible. Thus, expert recommendations are required for its management. Individuals and family should be informed of the importance of close screening and surveillance.

摘要

综述目的

林奇综合征是一种遗传性综合征,由错配修复基因的种系突变引发多种癌症。由于人群中缺乏系统筛查,其发病率被低估。上尿路尿路上皮癌是与该综合征相关的第三大常见癌症,泌尿外科医生应了解其诊断途径。

最新发现

林奇综合征可通过以下三个不同步骤确诊:符合临床标准、组织和基因检测以及家族遗传咨询。对于60岁以下的上尿路尿路上皮癌患者以及有提示性个人/家族病史的患者,必须怀疑该病。当怀疑诊断时,免疫组织化学和聚合酶链反应是下一步确认诊断的方法。确诊后,管理的关键是通过尿液分析和影像学检查以及对一级亲属进行筛查进行良好的监测,以预防疾病复发。

总结

尽管缺乏关于林奇综合征中上尿路尿路上皮癌的高级别研究,但其患病率不可忽视。因此,其管理需要专家建议。个人和家庭应被告知密切筛查和监测的重要性。

相似文献

1
Lynch syndrome in upper tract urothelial carcinoma: significance, screening, and surveillance.上尿路尿路上皮癌中的林奇综合征:意义、筛查及监测
Curr Opin Urol. 2017 Jan;27(1):48-55. doi: 10.1097/MOU.0000000000000340.
2
Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening.在全面筛查中DNA错配修复蛋白免疫组化表达缺失的上尿路尿路上皮癌患者的临床病理特征
Int J Urol. 2018 Feb;25(2):151-156. doi: 10.1111/iju.13481. Epub 2017 Nov 22.
3
Universal Point of Care Testing for Lynch Syndrome in Patients with Upper Tract Urothelial Carcinoma.上尿路尿路上皮癌患者林奇综合征的通用即时检测
J Urol. 2018 Jan;199(1):60-65. doi: 10.1016/j.juro.2017.08.002. Epub 2017 Aug 7.
4
Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.上尿路尿路上皮细胞癌及其他涉及遗传性非息肉病性结直肠癌(林奇综合征)肿瘤谱的泌尿生殖系统恶性肿瘤。
Eur Urol. 2008 Dec;54(6):1226-36. doi: 10.1016/j.eururo.2008.08.008. Epub 2008 Aug 12.
5
Lynch Syndrome: A Primer for Urologists and Panel Recommendations.林奇综合征:泌尿科医师指南和小组建议。
J Urol. 2015 Jul;194(1):21-9. doi: 10.1016/j.juro.2015.02.081. Epub 2015 Feb 21.
6
Prevalence of Lynch syndrome among patients with upper urinary tract carcinoma in a Japanese hospital-based population.在一家日本医院人群中,上尿路尿路上皮癌患者中林奇综合征的患病率。
Jpn J Clin Oncol. 2020 Jan 24;50(1):80-88. doi: 10.1093/jjco/hyz140.
7
Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.关于以下内容的编辑评论:上尿路尿路上皮癌及其他涉及遗传性非息肉病性结直肠癌(林奇综合征)肿瘤谱的泌尿系统恶性肿瘤。
Eur Urol. 2008 Dec;54(6):1235-6. doi: 10.1016/j.eururo.2008.08.009. Epub 2008 Aug 12.
8
A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool.一项多机构数据库分析显示,一部分遗传性上尿路尿路上皮癌根据分类被误诊为散发性:提出患者特异性风险识别工具。
BJU Int. 2012 Dec;110(11 Pt B):E583-9. doi: 10.1111/j.1464-410X.2012.11298.x. Epub 2012 Jun 15.
9
Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.关于“遗传性非息肉病性结直肠癌(林奇综合征)肿瘤谱中涉及的上尿路尿路上皮癌和其他泌尿系统恶性肿瘤”的社论评论
Eur Urol. 2008 Dec;54(6):1236. doi: 10.1016/j.eururo.2008.08.010. Epub 2008 Aug 12.
10
Lynch syndrome in urological practice: diagnosis, therapeutic strategies, and screening for upper tract urothelial carcinoma.泌尿外科临床中的林奇综合征:诊断、治疗策略及上尿路尿路上皮癌的筛查
Curr Opin Urol. 2022 Jan 1;32(1):40-47. doi: 10.1097/MOU.0000000000000936.

引用本文的文献

1
Lymphadenectomy in upper tract urothelial carcinoma: Clinical insights and controversies (Review).上尿路尿路上皮癌的淋巴结清扫术:临床见解与争议(综述)
Oncol Rep. 2025 Nov;54(5). doi: 10.3892/or.2025.8970. Epub 2025 Aug 14.
2
Hereditary and Familial Traits in Urological Cancers and Their Underlying Genes.泌尿系统癌症中的遗传和家族性特征及其相关基因
Eur Urol Open Sci. 2024 Sep 13;69:13-20. doi: 10.1016/j.euros.2024.08.011. eCollection 2024 Nov.
3
Clinicopathological characteristics, molecular landscape, and biomarker landscape for predicting the efficacy of PD-1/PD-L1 inhibitors in Chinese population with mismatch repair deficient urothelial carcinoma: a real-world study.
中国人群中错配修复缺陷型尿路上皮癌的临床病理特征、分子谱和生物标志物谱与 PD-1/PD-L1 抑制剂疗效预测的相关性:一项真实世界研究。
Front Immunol. 2023 Nov 6;14:1269097. doi: 10.3389/fimmu.2023.1269097. eCollection 2023.
4
Contemporary Issues in Urothelial Carcinoma of Upper Urinary Tract.上尿路尿路上皮癌的当代问题
Adv Anat Pathol. 2024 Mar 1;31(2):80-87. doi: 10.1097/PAP.0000000000000421. Epub 2023 Nov 27.
5
Gender-specific counselling of patients with upper tract urothelial carcinoma and Lynch syndrome.上尿路尿路上皮癌和林奇综合征患者的性别特异性咨询。
World J Urol. 2023 Jul;41(7):1741-1749. doi: 10.1007/s00345-023-04344-9. Epub 2023 Mar 24.
6
Relative Risk of Bladder and Kidney Cancer in Lynch Syndrome: Systematic Review and Meta-Analysis.林奇综合征中膀胱癌和肾癌的相对风险:系统评价与荟萃分析
Cancers (Basel). 2023 Jan 13;15(2):506. doi: 10.3390/cancers15020506.
7
Genitourinary manifestations of Lynch syndrome in the urological practice.林奇综合征在泌尿外科临床中的泌尿生殖系统表现
Asian J Urol. 2022 Oct;9(4):443-450. doi: 10.1016/j.ajur.2022.05.009. Epub 2022 Aug 31.
8
Uptake and outcomes of small intestinal and urinary tract cancer surveillance in Lynch syndrome.林奇综合征中小肠和尿路癌症监测的接受情况及结果
World J Clin Oncol. 2021 Nov 24;12(11):1023-1036. doi: 10.5306/wjco.v12.i11.1023.
9
Morphological predictors for microsatellite instability in urothelial carcinoma.尿路上皮癌中微卫星不稳定性的形态学预测因子。
Diagn Pathol. 2021 Nov 20;16(1):106. doi: 10.1186/s13000-021-01168-2.
10
Developing Precision Medicine for Bladder Cancer.开发膀胱癌精准医学。
Hematol Oncol Clin North Am. 2021 Jun;35(3):633-653. doi: 10.1016/j.hoc.2021.02.008. Epub 2021 Apr 10.